Velocity’s Boise research site was founded in 1991 as the first free-standing clinical research facility in the state of Idaho, and was acquired by Velocity in 2019. This site’s initial focus was on clinical studies for treatment of infectious diseases, participating in antibiotic trials across a wide range of indications. Over the following years, Boise developed the expertise and capabilities to become a significant site for conducting vaccine trials and clinical trials for chronic medical conditions.
Velocity Boise is located in Meridian, just west of the city of Boise and easily accessible to the entire metropolitan area known as the Treasure Valley. This area contains Idaho’s three largest cities, Boise, Meridian, and Nampa whose combined population makes it the most populous in the state. The Boise facility is located just off a major highway and less than one mile from a regional hospital.
All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Boise team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.
